Title

An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report

Division

North Florida

Hospital

Ocala

Document Type

Abstract

Publication Date

5-8-2020

Keywords

immune checkpoint inhibitors, drug-related side effects and adverse reactions

Disciplines

Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism

Publisher or Conference

Journal of the Endocrine Society

Share

COinS